Results 151 to 160 of about 227,288 (316)

The c-Src inhibitor eCF506 diminishes opioid tolerance creating bias against β-arrestin2 recruitment [PDF]

Samuel Singleton, Francesca Nunn, Álvaro Lorente‐Macías, Álvaro Lorente‐Macías, Rachel Toth, Asier Unciti‐Broceta, Tim G. Hales   +6 more
openalex   +1 more source

Distinction and mutual Influences between Parkinson's Disease‐related and unrelated Chronic Pain

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Chronic pain (i.e. > 3 months) is a common nonmotor symptom in patients with Parkinson's disease (PD), but the attribution to PD is critical for further treatment. Objectives We explored the PD Pain Classification System (PD‐PCS) criteria for the diagnosis of PD‐related pain and mutual influences between PD‐related and PD‐unrelated ...
Jonathan Hunger, Florian Brugger, Georg Kägi, Jens Carsten Möller, Nathalie Hollenstein, David H. Benninger, Michele Tinazzi, Julien F. Bally, Roman Gonzenbach, Daniel Ciampi de Andrade, Santiago Perez Lloret, Veit Mylius   +11 more
wiley   +1 more source

The majority of opioid prescriptions in Israel between 2010 and 2020 involved a small minority of physicians and of patients: policy implications. [PDF]

Isr J Health Policy Res
Kaliner E, Cohen MJ, Rose AJ, Dressler RL.   +3 more
europepmc   +1 more source

Opioid-Induced Constipation among a Convenience Sample of Patients with Cancer Pain [PDF]

, 2016
Karin S. Coyne, Christopher Sexton, Robert LoCasale, F. King, Mary Kay Margolis, Sam H. Ahmedzai   +5 more
openalex   +1 more source

Cerebrospinal Fluid Proenkephalin Predicts Striatal Atrophy Decades before Clinical Motor Diagnosis in Huntington's Disease

Movement Disorders, EarlyView.
Abstract Background Huntington's disease (HD) is characterized by early, selective, progressive vulnerability of striatal medium spiny neurons (MSNs). Proenkephalin (PENK), a precursor of opioid peptides abundantly expressed in MSNs, is a promising biomarker of striatal integrity, but region‐specific associations and its potential for early‐stage ...
Mena Farag, Michael J. Murphy, Nicola Z. Hobbs, Michela Leocadi, Kate Fayer, Olivia Thackeray, Johan Gobom, Marc Ciosi, Amanda Heslegrave, Henrik Zetterberg, Douglas R. Langbehn, Darren G. Monckton, Edward J. Wild, Sarah J. Tabrizi, Rachael I. Scahill   +14 more
wiley   +1 more source

Impact of Opioid Limiting Legislation on Prescribing in Adolescent Breast Surgery at a Tertiary Pediatric Hospital. [PDF]

Plast Reconstr Surg Glob Open
Kennedy CC, Qureshi AA, Czerniecki S, Blum KM, Lin SHY, Vasko AJ, Pearson GD, Bjorklund KA, Khansa I, Kirschner RE, Barker JC.   +10 more
europepmc   +1 more source

Opioid Antagonists [PDF]

Journal of Pain and Symptom Management, 2014
Victoria, Barnett, Robert, Twycross, Mary, Mihalyo, Andrew, Wilcock   +3 more
openaire   +2 more sources

Persisting high rates of mental health disorders in patients in opioid agonist treatment—Results from a 6‐year longitudinal study

Michael Soyka, Gabi Koller, Wittchen Hans‐Ulrich, Gerhard Bühringer   +3 more
openalex   +1 more source

Clinical Guidelines for the Use of Chronic Opioid Therapy in Chronic Noncancer Pain

, 2009
Roger Chou, Gilbert J. Fanciullo, Perry G. Fine, Jeremy Adler, Jane C. Ballantyne, Pamela Stitzlein Davies, Marilee I. Donovan, David A. Fishbain, K. Foley, Jeffrey Fudin, Aaron M. Gilson, Alexander Kelter, Alexander Mauskop, Patrick G. O’Connor, Steven D. Passik, Gavril W. Pasternak, Russell K. Portenoy, Ben A. Rich, Richard G. Roberts, Knox H. Todd, Christine Miaskowski   +20 more
openalex   +1 more source

Trends in co-prescribed opioids and benzodiazepines, non-prescribed opioids and benzodiazepines, and schedule-I drugs in the United States, 2013 to 2019

, 2023
Shaden A. Taha, Jordan Westra, Danyel H. Tacker, Mukaila A. Raji, Yong‐Fang Kuo   +4 more
openalex   +1 more source